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Abstract  
The in vitro anti-bacterial activity of auraptene and four prenyloxycinnamic and benzoic acids was evaluated against a panel of three bacterial strain. All 
compounds were shown to be active as inhibitory agents of the growth of Staphylococcus aureus. 
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Resumen 
La actividad antibacteriana in vitro del auraptene y de cuatro ácidos preniloxycinámicos y benzoicos ha sido evaluada sobre un grupo de tres distintas cepas 
bacterianas. Todos los compuestos mostraron ser activos como agentes inhibitorios del crecimiento del Staphylococcus Aureus. 
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INTRODUCTION 
Oxyprenylated natural products, such as 
isopentenyloxy- (C5), geranyloxy- (C10), and 
farnesyloxy- (C15) related compounds, represent a 
family of secondary metabolites that were considered 
for years to be merely biosynthetic intermediates of 
the more widespread C-prenylated derivatives. These 
secondary metabolites have been recognized in the last 
two decades as interesting and valuable biologically 
active phytochemicals. Approximately 300 
compounds have been isolated and structurally 
characterized from plants, primarily from the families 
Rutaceae, Compositae, Guttiferae, and Leguminosae, 
comprising several edible vegetables and fruits. The 
phytochemistry and pharmacology of 
prenyloxyphenylpropanoids was recently reviewed 
(Epifano et al., 2007).
 
Among these auraptene 1 
(Genovese and Epifano, 2011), boropinic acid 2 
(Curini et al., 2008), and 4'-geranyloxyferulic acid 3
 
(Curini et al., 2006) were shown to exert significant 
and appreciable biological effects as anti-cancer, anti-
protozoal, anti-fungal, anti-inflammatory, and anti-
oxidant agents. Aim of the current work was to study 
the anti-bacterial properties of these secondary 
metabolites together with those of two 
isopentenyloxycinnamic acids, namely valencic acid 4, 
previously isolated from plants of the genus Citrus, 
and 4'-isopentenyloxyvanillic acid 5, extracted from 
plants belonging to the genus Tricocholea (Epifano et 
al., 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
Both for the chemical synthesis of compounds 1-5 
(Genovese et al., 2009) and for the in vitro anti-
bacterial growth assays (agar diffusion method using 
Muellener-Hinton agar) (Richardson et al., 1968) the 
same general procedures as reported previously were 
followed. Analytical data (m.p., IR, 1H, 13C NMR, 
elemental analysis) for 1-5 were in full agreement with 
those previously reported for the same compounds 
(Genovese et al., 2009). The three bacterial strains 
used were Staphylococcus aureus ATCC 29213, 
Escherichia coli ATCC 700926, and Streptococcus 
mutans ATCC 25175. All phytochemicals were were 
dissolved in DMSO and tested in the concentration 
range 0.5 – 62.5 g/mL. 100 l of 18 h bacterial 
cultures were used to spread a lawn on the agar. The 
cultures were adjusted to 10
5
 CFU/ml using 
McFarland standard and solutions of each compound 
at the indicated concentration was added to each 
culture. The plates were left 30 min at room 
temperature for the diffusion of solutions containing 
compounds 1-5 and incubated at 37 °C for 18 h. The 
zones of inhibition were measured by a ruler and each 
experiment was repeated three times. Chloramphenicol 
was used as reference drug. 
 
RESULTS AND DISCUSSION 
Results of the inhibition of growth of the three 
bacterial strains under investigation, expresses as the 
minimum inhibitory concentration (MIC), are reported 
in the Table 1. 
The five compounds under investigation 
exhibited a different range of activity towards the three 
microrganisms. Streptococcus mutans was the less 
sensible and all products can be considered virtually 
inactive. 4'-Geranyloxyferulic acid, valencic acid, and 
'-isopentenyloxyvanillic acid were only slightly active 
on Escherichia coli, while auraptene and boropinic 
acid were found by far less potent than these three 
products. The most interesting results were obtained 
on the growth of Staphylococcus aureus. All 
compounds exhibited a significant activity with MIC 
ranging from 4.1 to 6.9 g/mL. These data are of 
interest considering that S. aureus is nowadays well 
recognized as one of the most dangerous bacterium 
able to lead to severe syndromes in humans as well as 
to resist to the most part of chemotherapeutics 
currently at disposition. In particular the phenomenon 
of resistance by S. aureus is growing all over the 
world (Rogers et al. 2011). 
 
CONCLUSIONS 
In this manuscript we studied the in vitro anti-bacterial 
properties and disclose a novel potential application of 
auraptene and oxyprenylated benzoic and cinnamic 
acids. The results obtained in the case of S. aureus will 
be further and better characterized in the next future  
O OO
1
R1
R2
OR3
2 R1 = CH=CH-COOH, R2 = OCH3, R
3 = H
3 R1 = CH=CH-COOH, R2 = OCH3, R
3 = isopentenyl
4 R1 = COOH, R2 = R3 = H
5 R1 = COOH, R2 = OCH3, R
3 = H 
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Table 1 
Antibacterial activity of selected prenyloxyphenylpropanoids 
 
 MIC ( g/mL) 
Compound Escherichia coli Staphylococcus aureus Streptococcus mutans 
1 30 6.9 > 62.5 
2 30 4.3 38 
3 10 5.3 23 
4 10 4.1 41 
5 10 5.3 23 
Chloramphenicol 5 5 15 
 
but, although preliminary, the data reported in this 
manuscript could be useful to identify novel 
therapeutic weapons against this extremely dangerous 
bacterium and prenyloxyphenylpropanoids as novel 
lead anti-bacterial compounds. In the mean time 
studies to evaluate the toxicological profile of these 
secondary metabolites are ongoing.  
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